PRKAA2 and triple-A syndrome: The in vivo study demonstrated that activation of AMPK signal pathway by AICAR reduced the incidence, severity and mortality of aneurysm, while the inhibition of AMPK signal pathway by Compound C tended to aggravate AAA progression.